Compare top Leukemia doctors and prices in Spain. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
6
Spain
Reviews
14,000+
From real patients
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Show first:
Specialist in bone marrow transplantation – Dr. Rives Sola focuses on pediatric hematology at SJD Barcelona Children's Hospital.
Award-winning pediatric oncologist specializing in childhood cancers – heads Hematology Oncology at SJD Barcelona Children's Hospital, ranked among Europe's best.
Dr. Cobo Valien leads the Hematologic Malignancies Unit at Centro Médico Teknon, specializing in leukemia with over 1,100 treatments performed.
Prof. Bosch leads global research in Chronic Lymphocytic Leukemia (CLL), with 80+ active clinical trials advancing new treatments.
Dr. López-Ibor specializes in pediatric leukemia with over 32 years of experience of experience, currently leading the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital.
Dr. Blanca Lopez Ibor leads the Hematology & Pediatric Oncology Unit at HM Hospitales, with over 31 years of experience of experience in pediatric hematology and oncology.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
896 patients from Spain have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | Pediatric bone marrow transplantation | Focuses exclusively on pediatric hematology with specialization in bone marrow transplants. Works at SJD Barcelona Children's Hospital – a top-tier facility for childhood leukemia treatment. | Spain | Price on request
| ||
| #2 | 30 years of experience | Pediatric leukemia & sarcomas | Leading researcher in childhood cancers with breakthrough treatments. Heads hematology oncology at top European children's hospital. Multiple international awards including Schweisguth Prize. | Spain | from
$416 | |
| #3 | 27 years of experience | CAR T-cell therapy | Specializes in CAR T-cell therapy for aggressive cancers. Leads the Hematologic Malignancies Unit and has performed 1,100+ treatments. Multiple award-winning researcher. | Spain | Price on request
| |
| #4 | 126 years of experience | Chronic lymphocytic leukemia (CLL) | World-renowned CLL researcher leading 80+ clinical trials. Heads Hematology at Vall d'Hebron Hospital and publishes in top journals like NEJM. | Spain | Price on request
| |
| #5 | 32 years of experience | Pediatric leukemia | Specializes exclusively in pediatric cases with a focus on leukemia and hematological diseases. Leads a dedicated unit at HM Montepríncipe Hospital. | Spain | Price on request
| |
| #6 | 31 years of experience | Pediatric hematological cancers | Leads a specialized Hematology & Pediatric Oncology Unit, with extensive training in the US. Heads two foundations dedicated to children's health during treatment. | Spain | from
$500 |
Spain is a leading global destination for CAR T-cell therapy. The country offers both commercial products and unique academic versions developed in hospitals. Specialist centers in Barcelona and Madrid provide these treatments for relapsed or refractory leukemia, lymphoma, and multiple myeloma.
Bookimed Expert Insight: Spain is unique because its hospitals develop their own CAR-T treatments under a special exemption. This allows academic centers like Hospital Clínic de Barcelona to offer therapy for approximately $90,000. This is significantly more affordable than commercial products that can exceed $350,000. For international patients, choosing an academic protocol in Barcelona can save over $200,000 while maintaining high safety standards.
Patient Consensus: Patients note that while the public system is excellent, the bureaucratic approval process for therapy can take 3 to 9 months. Many recommend consulting a specialist early to navigate regional differences and secure a slot in Madrid or Barcelona hospitals.
Spain is a global leader in leukemia treatment. Major centers in Barcelona and Madrid provide specialized therapies like CAR T-cell and bone marrow transplants. Facilities like Centro Médico Teknon and SJD Barcelona Children's Hospital hold prestigious Joint Commission International accreditation for oncology and hematology care.
Bookimed Expert Insight: Spanish oncology centers offer a rare combination of private comfort and heavy academic research. Clinica Universidad de Navarra serves over 700,000 patients from 70 countries. It was the first hospital in Spain to earn Joint Commission International accreditation. This reflects a long-standing commitment to safety and protocol that newer centers are still building.
Patient Consensus: Patients highlight that translators at centers like Centro Médico Teknon make the experience smooth. They often express relief at how clearly doctors explain subsequent medication phases.
International patients can join leukemia clinical trials in Spain. Participation depends on trial-specific inclusion criteria and sponsor approval. While enrollment is possible for early-phase studies, non-EU residents often require private funding for standard medical care. Specialized academic centers in Madrid and Barcelona currently lead these initiatives.
Bookimed Expert Insight: Quironsalud Madrid provides rare opportunities for free leukemia treatment within clinical trials if specific requirements are met. Our data shows that high-volume centers like Clínica Universidad de Navarra, which serves 700,000 patients from 70 countries, have more robust infrastructure for managing international trial participants compared to smaller regional clinics.
Patient Consensus: Patients note that Phase I and II studies in Spain often prioritize EU citizens due to funding rules. They suggest preparing private insurance and proof of self-funding early to avoid long enrollment delays.
Travel to Spain for leukemia therapy without prior authorization depends on your nationality and funding. EU citizens require an S2 form for public healthcare coverage. Private patients do not need state authorization but must secure a medical invitation from clinics like Centro Médico Teknon or Quironsalud Madrid.
Bookimed Expert Insight: Spain is a top-3 global destination on Bookimed, and the data reveals a heavy focus on high-volume centers in Barcelona and Madrid. While many look for general oncology, patients should target specific experts like Dr. Francesc Cobo Valien at Centro Médico Teknon or Dr. Francesc Bosch at Hospital Quiron Barcelona. These specialists have performed thousands of procedures and lead clinical trials, providing access to therapies often unavailable in smaller regional hospitals.
Patient Consensus: Patients note that traveling with a translator makes the experience much smoother. They also emphasize carrying a formal hospital invitation letter to avoid issues with immigration officials when entering Spain.
Barcelona and Madrid are Spain's primary hubs for leukemia specialists. Barcelona leads in pediatric care and research. Madrid offers the largest private bone marrow transplant programs. Pamplona remains a critical center due to the global reputation of Clínica Universidad de Navarra for hematology.
Bookimed Expert Insight: Barcelona clinics often serve as a bridge for advanced American protocols. Dr. Jaume Mora Graupera at SJD participated in fellowships at Memorial Sloan Kettering. This transatlantic connection brings US molecular pathology standards directly to Spanish hematology departments. It is a major reason why international patients favor Barcelona for pediatric leukemia.
Patient Consensus: Patients note that while Madrid and Barcelona offer the most specialists, the public centers like Vall d'Hebron are highly recommended. They often suggest confirming recent research breakthroughs for specific leukemia types before choosing a facility.
Spanish hospitals manage language barriers for leukemia patients through on-site certified translators and multilingual medical coordinators. Facilities utilize 24/7 remote interpretation for 180 languages to ensure accuracy. Leading centers provide dedicated international departments. These teams handle clinical documentation and treatment planning in the patient preferred language.
Bookimed Expert Insight: While many think only private clinics provide language support, leading institutions like Centro Médico Teknon or Clinica Universidad de Navarra maintain dedicated international departments that function as full-service communication hubs. Our data shows these coordinators handle everything from initial scans to complex follow-ups. This is why these hospitals consistently earn higher patient satisfaction ratings. Selecting a clinic with an established international department is often more effective than relying on translation apps alone.
Patient Consensus: Patients note that having a professional translator makes the entire medical experience smooth and easy to manage. They strongly advise booking interpreters through the international office specifically for consent forms and diagnostic test results.
Discuss the specific leukemia subtype and genetic markers like FLT3 during your first consultation. Inquire about cytogenetics and molecular testing to guide treatment. Ask about the multidisciplinary team and clinical trial eligibility available at Spanish centers like Quironsalud Madrid.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra maintain exceptional quality standards. This center reached a 95% rate of affected limb preservation in sarcoma. For leukemia patients, this indicates a deep focus on long-term functional survival. Seek clinics with JCI and ESMO accreditations to ensure high-level evidence-based care.
Patient Consensus: Patients note it is important to confirm wait times for cytogenetics. They also suggest requesting a translator to ensure every medical detail is clear.